Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00303
|
|||||
Drug Name |
L-leucine
|
|||||
Synonyms |
(2S)-2-amino-4-methylpentanoic acid; (2S)-alpha-leucine; (S)-(+)-Leucine; (S)-2-Amino-4-methylpentanoic acid; (S)-2-Amino-4-methylvaleric acid; (S)-Leucine; 2-amino-4-methylvaleric acid; 61-90-5; H-Leu-OH; L-(-)-2-Amino-4-methylpentanoic acid; L-Leuzin; L-Norvaline, 4-methyl-; L-alpha-Aminoisocaproic acid; L-leucin; LEUCINE, L-; Leucin; Leucin [German]; Leucina [INN-Spanish]; Leucina [Latin,Spanish]; Leucine (VAN); Leucine [USAN:INN]; Leucinum; Leucinum [INN-Latin]; alpha-Aminoisocaproic acid; leu; leucine
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Major depressive disorder [ICD11: 6A70.3] | Phase 2 | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C6H13NO2
|
|||||
Canonical SMILES |
CC(C)CC(C(=O)O)N
|
|||||
InChI |
InChI=1S/C6H13NO2/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t5-/m0/s1
|
|||||
InChIKey |
ROHFNLRQFUQHCH-YFKPBYRVSA-N
|
|||||
CAS Number |
CAS 61-90-5
|
|||||
Pharmaceutical Properties | Molecular Weight | 131.17 | Topological Polar Surface Area | 63.3 | ||
Heavy Atom Count | 9 | Rotatable Bond Count | 3 | |||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 3 | |||
XLogP |
-1.5
|
|||||
PubChem CID | ||||||
PubChem SID |
10317235
, 10530134
, 11459278
, 11459418
, 15146625
, 15218991
, 24874858
, 24886442
, 24896388
, 24896488
, 24896510
, 24901619
, 26651805
, 29225114
, 3423
, 4253012
, 46391850
, 46392412
, 46393330
, 46507163
, 46507999
, 48416162
, 49747925
, 49835907
, 49988821
, 50108366
, 57323191
, 57581300
, 57581304
, 57651866
, 57654329
, 57654969
, 57654972
, 57654976
, 595259
, 6436525
, 6436533
, 6436536
, 6436708
, 7847098
, 7888630
, 80033595
, 8025197
, 81044540
, 81055047
, 8143308
, 8153821
, 832925
, 838753
, 841561
|
|||||
ChEBI ID |
ChEBI:15603
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | LAT1 | Transporter Info | L-type amino acid transporter 1 | Substrate | [2] | |
LAT3 | Transporter Info | L-type amino acid transporter 3 | Substrate | [3] | ||
LAT4 | Transporter Info | L-type amino acid transporter 4 | Substrate | [4] | ||
References | ||||||
1 | ClinicalTrials.gov (NCT03079297) Rapid Antidepressant Effects of Leucine | |||||
2 | Bidirectional transport of amino acids regulates mTOR and autophagy. Cell. 2009 Feb 6;136(3):521-34. | |||||
3 | Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters. J Biol Chem. 2003 Oct 31;278(44):43838-45. | |||||
4 | Anticipation of food intake induces phosphorylation switch to regulate basolateral amino acid transporter LAT4 (SLC43A2) function. J Physiol. 2019 Jan;597(2):521-542. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.